Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis

Adorni, 2021, High density lipoprotein cholesterol efflux capacity and atherosclerosis in cardiovascular disease: pathophysiological aspects and pharmacological perspectives, Cells, 10, 574, 10.3390/cells10030574 Rader, 2009, The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis, J. Lipid Res., 50, S189, 10.1194/jlr.R800088-JLR200 Oshita, 2020, Association of cholesterol uptake capacity, a novel indicator for HDL functionality, and coronary plaque properties: an optical coherence tomography-based observational study, Clin. Chim. Acta Int. J. Clin. Chem., 503, 136, 10.1016/j.cca.2020.01.001 Soria-Florido, 2020, High density lipoprotein functionality and cardiovascular events and mortality: a systematic review and meta-analysis, Atherosclerosis, 302, 36, 10.1016/j.atherosclerosis.2020.04.015 Xie, 2021, A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis, Lipids Health Dis., 20, 18, 10.1186/s12944-021-01444-6 Ormseth, 2016, High-density lipoprotein function in rheumatoid arthritis, Curr. Opin. Lipidol., 27, 67, 10.1097/MOL.0000000000000256 Tejera-Segura, 2017, HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis, Arthritis Res. Ther., 19, 113, 10.1186/s13075-017-1311-3 Sacks, 2018, From high-density lipoprotein cholesterol to measurements of function: prospects for the development of tests for high-density lipoprotein functionality in cardiovascular disease, Arterioscler. Thromb. Vasc. Biol., 38, 487, 10.1161/ATVBAHA.117.307025 Ronda, 2014, Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus, Ann. Rheum. Dis., 73, 609, 10.1136/annrheumdis-2012-202914 Greco, 2020, Anti-atherogenic modification of serum lipoprotein function in patients with rheumatoid arthritis after tocilizumab treatment, a pilot study, J. Clin. Med., 9, 10.3390/jcm9072157 Karpouzas, 2023, ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in rheumatoid arthritis, J. Autoimmun., 136, 10.1016/j.jaut.2023.103029 de la Llera-Moya, 2010, The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages, Arterioscler. Thromb. Vasc. Biol., 30, 796, 10.1161/ATVBAHA.109.199158 Koseki, 2021, Current diagnosis and management of tangier disease, J. Atherosclerosis Thromb., 28, 802, 10.5551/jat.RV17053 Clee, 2000, Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes, J. Clin. Invest., 106, 1263, 10.1172/JCI10727 Joyce, 2002, The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice, Proc. Natl. Acad. Sci. U.S.A., 99, 407, 10.1073/pnas.012587699 Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N. Engl. J. Med., 359, 2195, 10.1056/NEJMoa0807646 An, 2016, Cardiovascular outcomes associated with lowering low-density lipoprotein cholesterol in rheumatoid arthritis and matched nonrheumatoid arthritis, J. Rheumatol., 43, 1989, 10.3899/jrheum.160110 Lee, 2018, Effects of statins on coronary atherosclerotic plaques: the PARADIGM Study, JACC Cardiovasc. Imaging, 11, 1475, 10.1016/j.jcmg.2018.04.015 Karpouzas, 2022, The impact of statins on coronary atherosclerosis progression and long-term cardiovascular disease risk in rheumatoid arthritis, Rheumatol. Oxf. Engl., 61, 1857, 10.1093/rheumatology/keab642 Ito, 2006, Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction, Pharmacotherapy, 26, 85S, 10.1592/phco.26.7part2.85S Kitas, 2019, TRACE RA Consortium, A multicenter, randomized, placebo-controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis, Arthritis Rheumatol. Hoboken NJ, 71, 1437, 10.1002/art.40892 Gomaraschi, 2015, Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function, Handb. Exp. Pharmacol., 224, 593, 10.1007/978-3-319-09665-0_19 Karpouzas, 2014, Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease, Ann. Rheum. Dis., 73, 1797, 10.1136/annrheumdis-2013-203617 Leipsic, 2014, SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee, J. Cardiovasc. Comput. Tomogr., 8, 342, 10.1016/j.jcct.2014.07.003 Iwasaki, 2016, Dynamic change of high-risk plaque detected by coronary computed tomographic angiography in patients with subclinical coronary artery disease, Int. J. Cardiovasc. Imag., 32, 1667, 10.1007/s10554-016-0957-2 Peters, 2010, EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis, Ann. Rheum. Dis., 69, 325, 10.1136/ard.2009.113696 Kulkarni, 1994, Quantification of cholesterol in all lipoprotein classes by the VAP-II method, J. Lipid Res., 35, 159, 10.1016/S0022-2275(20)40123-3 Ronda, 2015, Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism, Arthritis Rheumatol. Hoboken NJ., 67, 1155, 10.1002/art.39039 Goff, 2014, Circulation, 129, S49, 10.1161/01.cir.0000437741.48606.98 Grembowski, 2016, Health outcomes of population-based pharmacy outreach to increase statin use for prevention of cardiovascular disease in patients with diabetes, J. Manag. Care Spec. Pharm., 22, 909 Thygesen, 2012, Third universal definition of myocardial infarction, J. Am. Coll. Cardiol., 60, 1581, 10.1016/j.jacc.2012.08.001 Talbot, 2018, Determinants of cholesterol efflux capacity in humans, Prog. Lipid Res., 69, 21, 10.1016/j.plipres.2017.12.001 Carpentier, 2002, Changes in the concentration and composition of plasma lipoproteins during the acute phase response, Curr. Opin. Clin. Nutr. Metab. Care, 5, 153, 10.1097/00075197-200203000-00006 Calabresi, 2009, Functional LCAT is not required for macrophage cholesterol efflux to human serum, Atherosclerosis, 204, 141, 10.1016/j.atherosclerosis.2008.08.038 Charles-Schoeman, 2009, Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis, Arthritis Rheum., 60, 2870, 10.1002/art.24802 Charles-Schoeman, 2015, Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib, Arthritis Rheumatol. Hoboken NJ., 67, 616, 10.1002/art.38974 Assmann, 1996, High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport, Atherosclerosis, 124, S11, 10.1016/0021-9150(96)05852-2 Karpouzas, 2023, Serum cholesterol loading capacity on macrophages is regulated by seropositivity and C-reactive protein in rheumatoid arthritis patients, Rheumatology, 62, 1254, 10.1093/rheumatology/keac394 Karpouzas, 2022, Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis, RMD Open, 8, 10.1136/rmdopen-2022-002411 Dhaliwal, 2000, Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally, J. Lipid Res., 41, 1658, 10.1016/S0022-2275(20)31999-4 Duivenvoorden, 2011, Carriers of lecithin cholesterol acyltransferase gene mutations have accelerated atherogenesis as assessed by carotid 3.0-T magnetic resonance imaging, J. Am. Coll. Cardiol., 58, 2481, 10.1016/j.jacc.2010.11.092 Bu, 2017, Elevated levels of preβ1-high-density lipoprotein are associated with cholesterol ester transfer protein, the presence and severity of coronary artery disease, Lipids Health Dis., 16, 4, 10.1186/s12944-016-0394-1 Guey, 2011, Relation of increased prebeta-1 high-density lipoprotein levels to risk of coronary heart disease, Am. J. Cardiol., 108, 360, 10.1016/j.amjcard.2011.03.054 Kane, 2012, Prebeta-1 HDL and coronary heart disease, Curr. Opin. Lipidol., 23, 367, 10.1097/MOL.0b013e328353eef1 Asztalos, 2018, High-density lipoprotein particles, cell-cholesterol efflux, and coronary heart disease risk, Arterioscler. Thromb. Vasc. Biol., 38, 10.1161/ATVBAHA.118.311117 Santovito, 2020, High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion, Int. J. Cardiol., 299, 249, 10.1016/j.ijcard.2019.07.094 Shimizu, 2014, Rosuvastatin activates ATP-binding cassette transporter A1-dependent efflux ex vivo and promotes reverse cholesterol transport in macrophage cells in mice fed a high-fat diet, Arterioscler. Thromb. Vasc. Biol., 34, 2246, 10.1161/ATVBAHA.114.303715 Song, 2011, Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet, Lipids Health Dis., 10, 8, 10.1186/1476-511X-10-8 Taylor, 2011, Statins for the primary prevention of cardiovascular disease, Cochrane Database Syst. Rev., CD004816 Tanaka, 2020, High-density lipoproteins during sepsis: from bench to bedside, Crit. Care Lond. Engl., 24, 134, 10.1186/s13054-020-02860-3 Kassai, 2007, The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase, Clin. Biochem., 40, 1, 10.1016/j.clinbiochem.2006.05.016 George, 2021, MEDI6012: recombinant human lecithin cholesterol acyltransferase, high-density lipoprotein, and low-density lipoprotein receptor-mediated reverse cholesterol transport, J. Am. Heart Assoc., 10, 10.1161/JAHA.119.014572 Triolo, 2014, Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes, Eur. J. Clin. Invest., 44, 240, 10.1111/eci.12226 Miyamoto-Sasaki, 2013, Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients, J. Atherosclerosis Thromb., 20, 708, 10.5551/jat.17210 Andreini, 2012, A long-term prognostic value of coronary CT angiography in suspected coronary artery disease, JACC Cardiovasc, Imaging, 5, 690 Hou, 2012, Prognostic value of coronary CT angiography and calcium score for major adverse cardiac events in outpatients, JACC Cardiovasc. Imaging, 5, 990, 10.1016/j.jcmg.2012.06.006 Karpouzas, 2020, Biologics may prevent cardiovascular events in rheumatoid arthritis by Inhibiting coronary plaque formation and stabilizing high-risk lesions, Arthritis Rheumatol. Hoboken NJ, 72, 1467, 10.1002/art.41293 Huang, 2018, Effect of statin therapy on the prevention of new-onset acute coronary syndrome in patients with rheumatoid arthritis, Int. J. Cardiol., 253, 1, 10.1016/j.ijcard.2017.11.009